Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Madelief Schreuder Goedheijt
Institution:
The Netherlands Cancer Institute
Observed institution:
The Netherlands Cancer Institute
ORCID:
0009-0008-8079-853X
Observed ORCID:
0009-0008-8079-853X
OpenAlex ID:
A5114319516
Budget Impact Analysis of Hyperthermic Intraperitoneal Chemotherapy With Interval Cytoreductive Surgery in Ovarian Cancer
2025
·
Madelief Schreuder Goedheijt
, Ruby M. van Stein
, et al.
·
JCO Oncology Practice
·
1
Influence of cardiophrenic lymph nodes on survival in patients receiving hyperthermic intraperitoneal chemotherapy for ovarian cancer in the OVHIPEC-1 trial
2026
·
Madelief Schreuder Goedheijt
, S. Lot Aronson
, et al.
·
Gynecologic Oncology
Exploiting the synergistic effect of PARP inhibition with cisplatin and hyperthermia during interval cytoreductive surgery and HIPEC in ovarian cancer: the PROOV study - A phase I/II clinical trial
2026
·
Leah J. Frenkel
, Madelief Schreuder Goedheijt
, et al.
·
International Journal of Gynecological Cancer
The peritoneal cancer index as a predictor of surgical completeness and postoperative risk in interval cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for ovarian cancer
2026
·
Madelief Schreuder Goedheijt
, Iris J. Van Dam
, et al.
·
International Journal of Gynecological Cancer
Evaluating The Implementation And Outcomes Of The Tumor-First Testing Strategy For BRCA1/2 Pathogenic Variants In Ovarian Cancer Patients: A Center-Wide Analysis
2025
·
Madelief Schreuder Goedheijt
, Lizet E. Van Der Kolk
, et al.
·
International Journal of Gynecological Cancer
The Prognostic And Predictive Value Of Cardiophrenic Lymph Nodes In Patients Receiving Hyperthermic Intraperitoneal Chemotherapy For Ovarian Cancer In The OVHIPEC-1 Trial
2025
·
Madelief Schreuder Goedheijt
, S. Lot Aronson
, et al.
·
International Journal of Gynecological Cancer
EV322/#473 The role of cardiophrenic lymph nodes in patients receiving hyperthermic intraperitoneal chemotherapy for ovarian cancer in the OVHIPEC-1 trial
2024
·
Madelief Schreuder Goedheijt
, S. Lot Aronson
, et al.
·
International Journal of Gynecological Cancer
PDF
EV321/#1109 A budget impact analysis of the addition of hyperthermic intraperitoneal chemotherapy to interval cytoreductive surgery in ovarian cancer
2024
·
Madelief Schreuder Goedheijt
, Ruby Van Stein
, et al.
·
International Journal of Gynecological Cancer
PDF
Show more works
View as search
Works count:
8
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type